Continuous subcutaneous infusion of morphine in children with cancer

Area of Science:

• Pediatric Oncology
• Pain Management
• Palliative Care

Background:

• Severe pain is a common and debilitating symptom in children with malignant neoplasms.
• Effective pain management is crucial for improving the quality of life in pediatric cancer patients.

Purpose of the Study:

• To evaluate the efficacy and safety of subcutaneous morphine sulfate infusion for severe pain in children with cancer.
• To assess the feasibility of using syringe pumps for continuous subcutaneous morphine administration in this population.

Main Methods:

• A prospective study involving seventeen children with severe pain due to malignant neoplasm.
• Treatment administered via continuous subcutaneous infusion of morphine sulfate using a syringe pump.
• Dosage titration based on patient response and pain assessment.

Main Results:

• Successful pain relief was achieved in all seventeen children.
• Adequate pain control was obtained without significant adverse events.
• The median morphine dosage required was 0.06 mg/kg/hr (range, 0.025–1.79 mg/kg/hr).
• Three patients were managed with home-based subcutaneous infusions.
• No patient required an intravenous line for pain management.

Conclusions:

• Continuous subcutaneous infusion of morphine sulfate via syringe pump is an effective and safe method for managing severe pain in pediatric cancer patients.
• This approach offers a viable alternative to intravenous administration, improving patient comfort and potentially facilitating home care.
• Syringe pump delivery allows for precise titration and sustained pain relief in this challenging patient group.